Selly Ba
Overview
Explore the profile of Selly Ba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newman C, Nayebare A, Gacko N, Okello P, Gueye A, Bijou S, et al.
Hum Resour Health
. 2023 May;
21(1):37.
PMID: 37143069
This commentary brings together theory, evidence and lessons from 15 years of gender and HRH analyses conducted in health systems in six WHO regions to address selected data-related aspects of...
2.
Li Z, Winer R, Ba S, Sy M, Lin J, Feng Q, et al.
J Infect Dis
. 2022 Oct;
227(9):1088-1096.
PMID: 36314598
Background: Persistent infection with high-risk human papillomavirus (HPV) is associated with development of invasive cervical cancer. Methods: Longitudinal data was collected from 174 Senegalese women. We employed marginal Cox proportional...
3.
Raugi D, Ba S, Cisse O, Diallo K, Tamba I, Ndour C, et al.
Clin Infect Dis
. 2021 Feb;
72(3):369-378.
PMID: 33527119
Background: Programmatic treatment outcome data for people living with human immunodeficiency virus type 2 (HIV-2) in West Africa, where the virus is most prevalent, are scarce. Methods: Adults with HIV-2...
4.
Ba S, Dia-Badiane N, Hawes S, Fortes Deguenonvo L, Sall F, Ndour C, et al.
Pan Afr Med J
. 2019 Nov;
33:222.
PMID: 31692792
Introduction: HIV-2, endemic in West Africa, has a natural resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) which makes it difficult to treat it in developing countries. Methods: We conducted a...
5.
Osterman A, Winer R, Gottlieb G, Sy M, Ba S, Dembele B, et al.
Int J Cancer
. 2018 Aug;
144(6):1302-1312.
PMID: 30144025
Female genital mutilation or cutting (FGM/C) is a traditional practice that affects a significant portion of women in sub-Saharan Africa, Egypt, areas of the Middle East and some countries in...
6.
Smith R, Wu V, Zavala C, Raugi D, Ba S, Seydi M, et al.
Antimicrob Agents Chemother
. 2018 Jul;
62(10).
PMID: 30012774
We examined the antiviral activity of the integrase inhibitor (INI) cabotegravir against HIV-2 isolates from INI-naive individuals. HIV-2 was sensitive to cabotegravir in single-cycle and spreading-infection assays, with 50% effective...
7.
Ba S, Raugi D, Smith R, Sall F, Faye K, Hawes S, et al.
Clin Infect Dis
. 2018 Apr;
67(10):1588-1594.
PMID: 29672676
Background: There is an urgent need for safe and effective antiretroviral therapy (ART) for human immunodeficiency virus type 2 (HIV-2) infection. We undertook the first clinical trial of a single-tablet...
8.
Chang M, Steinmetzer K, Raugi D, Smith R, Ba S, Sall F, et al.
J Clin Virol
. 2017 Nov;
97:22-25.
PMID: 29096389
Background: The Alere q HIV-1/2 Detect test (Alere Detect) is a rapid point-of-care (POC) nucleic acid test (NAT) that can detect and differentiate HIV-1 and HIV-2 in 25-μL whole blood...
9.
Benzekri N, Sambou J, Diaw B, Sall E, Sall F, Niang A, et al.
AIDS Care
. 2017 Jun;
29(12):1510-1516.
PMID: 28612658
An understanding of the factors contributing to food insecurity and malnutrition among people living with HIV (PLHIV) in Senegal is urgently needed in order to develop effective interventions. The goals...
10.
Wu V, Smith R, Masoum S, Raugi D, Ba S, Seydi M, et al.
Antimicrob Agents Chemother
. 2017 Jun;
61(8).
PMID: 28559249
There is a pressing need to identify more effective antiretroviral drugs for HIV-2 treatment. Here, we show that the investigational compound MK-8591 (4'-ethynyl-2-fluoro-2'-deoxyadenosine [EFdA]) is highly active against group A...